Pharma is the new tech; sector to remain a top bet despite potential US tariffs, says N Jayakumar
Pharmaceutical stocks remain one of the top investment bets despite concerns over potential US tariffs, according to N Jayakumar, Group CEO and Managing Director of Prime Securities. He said the sector’s export-driven nature, relatively low correlation with domestic economic cycles and long-term growth prospects make it an attractive investment theme. “Pharma is the new tech….
